HHS to Continue Value-Based Care Efforts

HHS and Congress will continue to align their efforts to replace fee-for-service payments with value based alternatives.

According to Deloitte, this shift to value-based reimbursement models creates a new paradigm in which care is delivered by an entire coordinated care community sharing in the responsibility—and risk—of outcomes and costs, touching almost every part of the health care delivery operation.

While this delivery system reform has been in the works for over a decade, the 2015 passage of the Medicare Access and CHIP Reauthorization Act (MACRA) has accelerated its momentum. The concept is to drive payment reform through creating new ways to pay physicians for Medicare beneficiaries, as well as create new funding for technical assistance, while also establishing new programs and requirements for data sharing and new federal advisory groups. It also repeals the Sustainable Growth Rate (SGR) formula that was previously used by the Centers for Medicare and Medicaid Services (CMS) to control spending by Medicare for physicians.

In doing so, MACRA helps to modernize the way Medicare will pay for physician services through rewarding value over volume. This is achieved by providing bonuses and penalties that are tied to performance.  In other words, providers are paid more or less depending on their performance compared to a quality and efficiencies threshold. With these incentives, providers may develop and participate in different models of healthcare delivery that were implemented under the Medicare Quality Payment Program (QPP), known as merit-based incentive payment system (MIPS) and advanced alternative payment model (APM).

Under MIPS, providers are evaluated and paid based on quality, resource use, clinical practice improvement, and meaningful use of a certified electronic health records (EHR) system. During the 2017PY, CMS has estimated that 592,000 to 642,000 providers will be eligible to participate.

APM is a payment approach that provides additional incentive payments to high quality and cost effective care. It allows physicians to earn a 5% lump sum incentive payment each year from 2019 to 2024 and avoid IRS reporting requirements and payment adjustments. In 2019, Advanced APMs will earn this 5% incentive for their 2017 participation if they meet certain requirements. This includes receiving 25% of their Medicare Part B payments through an Advanced APM in addition to seeing 20% of their Medicare Patients through an Advanced APM.  To qualify for advanced APMs there are three requirements that must be met: (1) utilize certified EHR technology; (2) Base payments on quality measures comparable to MIPs; and (3) be approved by CMS.

An important element of this shift will involve developing relationships and capabilities that align with value-based priorities. This would include alignment and collaboration between payers, providers, and consumers. Integration across all sectors are required in order to make this shift effective.

Source Link

 

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square